Anabel D. Bergeron
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Navigating the multifaceted intricacies of the Na+-Cl- cotransporter, a highly regulated key effector in the control of hydromineral homeostasis.
Journal: Physiological reviews
Published: February 08, 2024
High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity.
Journal: Scientific reports
Published: January 16, 2024
Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma.
Journal: The British journal of dermatology
Published: July 11, 2023
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 06, 2023
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy.
Journal: Molecular therapy oncolytics
Published: November 13, 2021
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Journal: Communications biology
Published: September 05, 2019
Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: May 07, 2019
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.
Journal: Science translational medicine
Published: August 21, 2017
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 23, 2017
Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.
Journal: International journal of cancer
Published: May 03, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026